Keener Financial Planning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$700K Sell
605
-8
-1% -$9.44K 0.25% 25
2026
Q2
$735K Sell
613
-29
-5% -$29.6K 0.26% 23
2026
Q1
$590K Hold
642
– – 0.25% 25
2025
Q4
$689K Sell
642
-22
-3% -$21K 0.3% 20
2025
Q3
$506K Hold
664
– – 0.23% 26
2025
Q2
$517K Hold
664
– – 0.26% 24
2025
Q1
$548K Buy
664
+130
+24% +$108K 0.36% 19
2024
Q4
$412K Hold
534
– – 0.24% 29
2024
Q3
$473K Hold
534
– – 0.31% 24
2024
Q2
$483K Hold
534
– – 0.32% 24
2024
Q1
$416K Hold
534
– – 0.29% 25
2023
Q4
$311K Buy
+534
New +$312K 0.24% 27

Other funds holding LLY

Keener Financial Planning's LLY Position: Q3 2026 in Review

Keener Financial Planning reduced its Eli Lilly (LLY) stake by 1.3% in Q3 2026, selling an estimated $9.44K and leaving 605 shares worth $700K. The position accounts for 0.25% of the portfolio, ranked #25.

Keener Financial Planning first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. The position peaked at $735K in Q2 2026. 4,629 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Keener Financial Planning held 605 shares of Eli Lilly worth $700K as of Q3 2026.
  • Keener Financial Planning sold 8 Eli Lilly shares in Q3 2026, an estimated $9.44K.
  • Eli Lilly made up 0.25% of Keener Financial Planning's portfolio in Q3 2026, its #25 holding.
  • Keener Financial Planning first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
  • Keener Financial Planning's Eli Lilly position peaked at $735K in Q2 2026.
  • 4,629 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Keener Financial Planning's 13F filing for Q3 2026, filed 6 Nov 2026.